The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma
Abstract
A mechanism decreasing oxidative metabolism during normal cell division and growth is expected to direct substrates toward biosyntheses rather than toward complete oxidation to CO(2). Hence, any event decreasing oxidative phosphorylations (OXPHOS) could provide a proliferating advantage to a transformed or tumor cell in an oxidative tissue. To test this hypothesis, we studied mitochondrial enzymes, DNA and OXPHOS protein content in three types of renal tumors from 25 patients. Renal cell carcinomas (RCCs) of clear cell type (CCRCCs) originate from the proximal tubule and are most aggressive. Chromophilic RCCs, from similar proximal origin, are less aggressive. The benign renal oncocytomas originate from collecting duct cells. Mitochondrial enzyme and DNA contents in all tumor types or grades differed significantly from normal tissue. Mitochondrial impairment increased from the less aggressive to the most aggressive RCCs, and correlated with a considerably decreased content of OXPHOS complexes (complexes II, III, and IV of the respiratory chain, and ATPase/ATP synthase) rather than to the mitochondrial content (citrate synthase and mitochondrial (mt)DNA). In benign oncocytoma, some mitochondrial parameters (mtDNA, citrate synthase, and complex IV) were increased 4- to 7-fold, and some were slightly increased by a factor of 2 (complex V) or close to normal (complexes II and III). A low content of complex V protein was found in all CCRCC and chromophilic tumors studied. However F(1)-ATPase activity was not consistently decreased and its impairment was associated with increased aggressiveness in CCRCCs. Immunodetection of free F(1)-sector of complex V demonstrated a disturbed assembly/stability of complex V in several CCRCC and chromophilic tumors. All results are in agreement with the hypothesis that a decreased OXPHOS capacity favors faster growth or increased invasiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
(1989) · PubMed · Cited by 3,343
Motzer, R. J., Bander, N. H., & Nanus, D. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351207 · Cited by 2,219
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Supercomplexes in the respiratory chains of yeast and mammalian mitochondria
Schägger, H., & Pfeiffer, K. (2000) · The EMBO Journal · doi:10.1093/emboj/19.8.1777 · Cited by 1,356
Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation
Pullman, M. E., Penefsky, H. S., Datta, A., & Racker, E. (1960) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)81361-1 · Cited by 1,317
Biochemical and molecular investigations in respiratory chain deficiencies
Rustin, P., Chretien, D., Bourgeron, T., Gérard, B., Rötig, A., Saudubray, J. M., & Munnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90055-8 · Cited by 1,243
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G., & Goldberg, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10595 · Cited by 892
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
Stebbins, C. E., Kaelin, W. G., & Pavletich, N. P. (1999) · Science · doi:10.1126/science.284.5413.455 · Cited by 860
Tumor Mitochondria and the Bioenergetics of Cancer Cells
Pedersen, P. L. (2015) · Progress in Tumor Research · doi:10.1159/000401202 · Cited by 711
Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., Oldfield, E. H., Klausner, R. D., & Linehan, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10589 · Cited by 531
Schägger, H., & Pfeiffer, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106474200 · Cited by 403
Expression Profiling of Renal Epithelial Neoplasms
Young, A. N., Amin, M. B., Moreno, C. S., Lim, S. D., Cohen, C., Petros, J. A., Marshall, F. F., & Neish, A. S. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64120-x · Cited by 311
Mathupala, S. P., Rempel, A., & Pedersen, P. L. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022494613613 · Cited by 248
The von Hippel–Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
Pause, A., Lee, S., Lonergan, K. M., & Klausner, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.993 · Cited by 238
Chapter 13 Blue-native gels to isolate protein complexes from mitochondria
Schägger, H. (2001) · Methods in Cell Biology · doi:10.1016/s0091-679x(01)65014-3 · Cited by 237
Buchet, K., & Godinot, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22983 · Cited by 226
The VHL tumour-suppressor gene paradigm
Kaelin, W. G., & Maher, E. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01558-3 · Cited by 213
HISTOPATHOLOGY AND MOLECULAR GENETICS OF RENAL TUMORS: TOWARD UNIFICATION OF A CLASSIFICATION SYSTEM
ZAMBRANO, N. R., LUBENSKY, I. A., MERINO, M. J., LINEHAN, W. M., & WALTHER, M. M. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68259-6 · Cited by 167
Appleby, R. D., Porteous, W. K., Hughes, G., James, A. M., Shannon, D., Wei, Y., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00350.x · Cited by 164
Reference charts for respiratory chain activities in human tissues
Chrétien, D., Rustin, P., Bourgeron, T., Rötig, A., Saudubray, J., & Münnich, A. (1994) · Clinica Chimica Acta · doi:10.1016/0009-8981(94)90056-6 · Cited by 141
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma
Gnarra, J. R., Duan, D. R., Weng, Y., Humphrey, J. S., Chen, D. Y. T., Lee, S. B., Pause, A., Dudley, C. F., Latif, F., Kuzmin, I., et al. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(95)00012-5 · Cited by 130
Metabolic Substrates, Cellular Energy Production, and the Regulation of Proximal Tubular Transport
Mandel, L. J. (1985) · Annual Review of Physiology · doi:10.1146/annurev.ph.47.030185.000505 · Cited by 124
Defective Mitochondrial ATP Synthesis in Oxyphilic Thyroid Tumors
Savagner, F., Franc, B., Guyétant, S., Rodien, P., Reynier, P., & Malthièry, Y. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4920 · Cited by 107
Mitochondrial Biogenesis in the Liver during Development and Oncogenesis
Cuezva, J. M., Ostronoff, L. K., RICART, J., de Heredia, M. L., Liegro, C. M. D., & Izquierdo, J. M. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022450831360 · Cited by 104
The IF1 inhibitor protein of the mitochondrial F1F0-ATPase
Green, D. W., & Grover, G. J. (2000) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(00)00085-2 · Cited by 100
Sodhi, C. P., Phadke, S. A., BATLLE, D. C., & Sahai, A. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.4.f667 · Cited by 88
Functions of the von Hippel–Lindau tumour suppressor protein
Kaelin, Iliopoulos, Lonergan, & Ohh (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00335.x · Cited by 73
Role of Exon 2-encoded β-Domain of the von Hippel-Lindau Tumor Suppressor Protein
Bonicalzi, M.-E., Groulx, I., de Paulsen, N., & Lee, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008295200 · Cited by 68
Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma.
Selvanayagam, P., & Rajaraman, S. (1996) · PubMed · Cited by 65
Genetic and clinical aspects of familial renal neoplasms.
Iliopoulos, O., & Eng, C. (2000) · PubMed · Cited by 53
Carbohydrate metabolism in human renal clear cell carcinomas.
Steinberg, P., Störkel, S., Oesch, F., & Thoenes, W. (1992) · PubMed · Cited by 45
Somatic mutations of von Hippel‐Lindau (VHL) tumor‐suppressor gene in european kidney cancers
Bailly, M., Bain, C., Favrot, M., & Öztürk, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630510 · Cited by 38
Intermediary metabolism of fast-growth tumor cells.
Rodríguez‐Enríquez, S., & Moreno‐Sánchez, R. (1998) · PubMed · Cited by 29
Cited by
Wu, M., Neilson, A., Swift, A. L., Moran, R., Tamagnine, J., Parslow, D., Armistead, S., Lemire, K., Orrell, J., Teich, J., et al. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00247.2006 · Cited by 918
Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K. I., Dang, C. V., & Semenza, G. L. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.001 · Cited by 885
Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells
Rossignol, R., Gilkerson, R., Aggeler, R., Yamagata, K., Remington, S. J., & Capaldi, R. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1101 · Cited by 840
Seyfried, T. N., & Shelton, L. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-7 · Cited by 644
Mitochondria in cancer cells: what is so special about them?
Gogvadze, V., Orrenius, S., & Zhivotovsky, B. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.01.006 · Cited by 637
Metadata
- Authors
- Simonnet, H.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-01
- Volume
- 23
- Issue
- 5
- Pages
- 759-768
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2147031820
- Cited by
- 347
- References
- 35
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.